RANBAXY Australia has moved to
quell concerns following a voluntary
recall of some batches of Troval
(atorvastatin) in the US.
“Ranbaxy's American subsidiary has
announced a voluntary recall of some
batches of the atorvastatin calcium
tablet that it has supplied in the
USA,” a statement from the
company said.
“This recall does not affect
batches of atorvastatin supplied to
the Australian market and will not
impact on supply in Australia.
“Atorvastatin supplied to the
Australian market is manufactured
at a different facility to the stock for
the US,” the statement added.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Nov 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Nov 12
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.